Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance

scientific article published on 28 December 2012

Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.01581-12
P932PMC publication ID3591863
P698PubMed publication ID23274661
P5875ResearchGate publication ID234011313

P50authorAndreas DötschQ38318250
Susanne HäusslerQ42673764
Iris ChabernyQ42801671
Sebastian BruchmannQ57191622
P2093author name stringBianka Nouri
P2860cites workDNA gyrase, topoisomerase IV, and the 4-quinolonesQ24643546
Site-directed mutagenesis by overlap extension using the polymerase chain reactionQ27860503
Primer3 on the WWW for general users and for biologist programmersQ27861030
Selection of resistant bacteria at very low antibiotic concentrationsQ28479239
A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutantsQ29547327
High throughput automated allele frequency estimation by pyrosequencingQ33352030
Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibilityQ33372694
Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosaQ33424246
Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.Q33975861
Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.Q33976675
Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolatesQ33981394
Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistanceQ33982709
Mechanism of plasmid-mediated quinolone resistanceQ34025874
The worldwide emergence of plasmid-mediated quinolone resistanceQ34569740
Fluoroquinolone antimicrobial agentsQ34613302
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesQ34750112
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter studyQ34932869
Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.Q35107937
Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenemQ35119495
The mutant selection window and antimicrobial resistanceQ35153856
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitroQ35821472
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coliQ35879095
Efflux-mediated antimicrobial resistanceQ36138147
Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment optionsQ36268383
Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutationQ36295397
Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosaQ37348842
Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unitQ37401036
Quinolones: action and resistance updatedQ37595559
Parallel evolution and local differentiation in quinolone resistance in Pseudomonas aeruginosaQ37835568
Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.Q38626934
Bacterial resistance to the quinolone antimicrobial agentsQ38746710
Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolonesQ39469894
Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosaQ39470847
Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patientsQ39473195
Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).Q39477717
Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacinQ39698735
Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa.Q39785139
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliQ39816339
Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosaQ39816347
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Q40334912
Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coliQ41788804
The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosaQ43184919
Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patientsQ44067245
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impactQ44132698
Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosaQ44426754
Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strainsQ44786412
Contribution of ParE mutation and efflux to ciprofloxacin resistance in Pseudomonas aeruginosa clinical isolatesQ46172031
Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosaQ46397999
Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolatesQ46412289
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferaseQ46862305
Small, stable shuttle vectors based on the minimal pVS1 replicon for use in gram-negative, plant-associated bacteria.Q47887383
Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.Q54105307
Contributions of efflux pumps to high level resistance of Pseudomonas aeruginosa to ciprofloxacinQ79664046
Pyrosequencing protocol using a universal biotinylated primer for mutation detection and SNP genotypingQ80643394
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectPseudomonas aeruginosaQ31856
P304page(s)1361-1368
P577publication date2012-12-28
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleQuantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance
P478volume57

Reverse relations

cites work (P2860)
Q64914064Amsacrine Derivatives Selectively Inhibit Mycobacterial Topoisomerase I (TopA), Impair M. smegmatis Growth and Disturb Chromosome Replication.
Q59126430Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa
Q57060635BACTOME-a reference database to explore the sequence- and gene expression-variation landscape of Pseudomonas aeruginosa clinical isolates
Q40108765Biofilm formation and antibiotic susceptibility in dispersed cells versus planktonic cells from clinical, industry and environmental origins.
Q98215924Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa
Q98245614Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolates
Q34992258Efflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon
Q37712123Evolution and Epidemiology of Multidrug-Resistant Klebsiella pneumoniae in the United Kingdom and Ireland
Q41066625Evolution of Cost-Free Resistance under Fluctuating Drug Selection in Pseudomonas aeruginosa
Q40056971Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.
Q36262179High-throughput automated microfluidic sample preparation for accurate microbial genomics.
Q38856197Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
Q38977280In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection
Q41060499In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure.
Q90472440Long-term Persistence of an Extensively Drug Resistant Subclade of Globally Distributed Pseudomonas aeruginosa Clonal Complex 446 in an Academic Medical Center
Q64100644MexXY Multidrug Efflux System Is More Frequently Overexpressed in Ciprofloxacin Resistant French Clinical Isolates Compared to Hospital Environment Ones
Q40559371Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients
Q64238157Mutations in play an important role in ciprofloxacin-resistant
Q61449168Persistence and Microevolution of in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study
Q89671585Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics
Q92429989Regulatory Mechanisms of the LuxS/AI-2 System and Bacterial Resistance
Q41687386Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor
Q52313185The Versatile Mutational Resistome of Pseudomonas aeruginosa.
Q35482558The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria
Q42659717The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach
Q34922676The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility
Q37120056Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa
Q61444724Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa
Q35062974Whole genome and transcriptome analyses of environmental antibiotic sensitive and multi-resistant Pseudomonas aeruginosa isolates exposed to waste water and tap water.
Q62899027Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre
Q36300937Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis

Search more.